Cara Therapeutics' initial stages of its Phase 3 trial for the Korsuva injection yielded positive results, drawing more investors to the company.
Breast cancer is one of the most common cancer types diagnosed in the world. G1 therapeutics drug trilaciclib may help beat it.
Amgen's AMG 510 was a highlight at the 2019 American Society of Clinical Oncology meeting.
BXT-25 is capable of perfusing clots in brain and heart. FDA approval process is based on easily defined surrogate markers. There’s an enormous licensing potential of...
Parents of children with serious health conditions are facing high costs of healthcare.
Preventable diseases still kill one in four people around the world. Medical science, early interventions and lifestyle changes could prevent millions of early deaths from diabetes,...
What kind of changes should people expect when it comes to the United States’ health infrastructure?
Microsoft announced a strategic partnership with Walgreens Boots Alliance, with the long-term goal of lowering the cost of health care.
Seeing the uprising number of healthcare mobile apps, are you wondering if you need to invest in one? Here are some things to consider for effective...
Eli Lilly & Co. makes second major pharmaceutical deal this year by paying cancer drug specialists Loxo Oncology $8 billion.